|
KMID : 0043320180410040450
|
|
Archives of Pharmacal Research
2018 Volume.41 No. 4 p.450 ~ p.458
|
|
|
Development of a simultaneous LC?MS/MS method to predict in vivo drug?drug interaction in mice
|
|
Jo Jung-Jae
Jo Jun-Hyun
Kim Sun-Joo
Lee Jae-Mok
Lee Sang-Kyu
|
|
|
Abstract
|
|
|
|
Cocktail substrates are useful in investigating drug?drug interactions (DDI) that can rapidly identify the cytochrome P450 (CYP) isoforms that interact with test drugs. In this study, we developed and validated five probe drugs for CYP1A, CYP2B, CYP2C, CYP2D, and CYP3A using LC?MS/MS to determine CYP activities in mice. The five probe substrates were caffeine (2 mg/kg), bupropion (30 mg/kg), omeprazole (4 mg/kg), dextromethorphan (40 mg/kg), and midazolam (2 mg/kg) for CYP1A, CYP2B, CYP2C, CYP2D, and CYP3A, respectively. The cocktail substrates were orally administered to male 5-week-old ICR mice over 0?240 min. The analytical method was validated; it showed high selectivity, linearity, and acceptable accuracy. We confirmed the lack of interaction of this cocktail in the control state (no effect of CYP inducer or inhibitor) and suggested AUCratio (metabolite/substrate) as a unit to evaluate DDI in vivo. In addition, the cocktail assay was applied for the determination of pharmacokinetic parameters against phenobarbital as a selective CYP2B inducer and ketoconazole as a strong CYP3A inhibitor. The concentration of cocktail substrates and the LC?MS/MS method were optimized. In conclusion, we developed a simultaneous and comprehensive analysis system for predicting potential DDI in mice.
|
|
|
KEYWORD
|
|
|
Cytochrome P450, Cocktail-assay, Drug-drug interaction, LC-MS/MS
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|